Altered virus may expand patient recruitment in human gene therapy trials
For many patients, participating in gene therapy clinical trials isn't an option because their immune system recognizes and fights the helpful virus used for treatment. Now, University of Florida Health and University of North Carolina researchers have found a solution that may allow it to evade the body's normal immune response.
Start the conversation, or Read more at EurekAlert!.